Investor's Business Daily on MSN3h
IBD Rating Upgrades: Chesapeake Utilities Flashes Improved Relative Price Strength
A Relative Strength Rating upgrade for Chesapeake Utilities shows improving technical performance. Will it continue?
Spyre Therapeutics Advances IBD Treatment Pipeline
Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.
Investor's Business Daily on MSN3d
IBD Rating Upgrades: Healthpeak Properties Shows Improved Relative Price Strength
Healthpeak Properties shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
News Medical3d
New biomarker could predict response to IBD treatment
Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.